Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis
The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Abstract
Hereditary hemochromatosis is a prevalent genetic disorder of iron hyperabsorption leading to hyperferremia, tissue iron deposition and complications including cirrhosis, hepatocarcinoma, cardiomyopathy and diabetes. Most individuals affected with hereditary hemochromatosis are homozygous with respect to a missense mutation that disrupts the conformation of HFE, an atypical HLA class I molecule (ref. 1; OMIM 235200). Mice lacking Hfe or producing a C282Y mutant Hfe protein develop hyperferremia and have high hepatic iron levels. In both humans and mice, hereditary hemochromatosis is associated with a paucity of iron in reticuloendothelial cells. It has been suggested that HFE modulates uptake of transferrin-bound iron by undifferentiated intestinal crypt cells, thereby programming the absorptive capacity of enterocytes derived from these cells; however, this model is unproven and controversial. Hepcidin, a peptide hormone (HAMP; OMIM 606464), seems to act in the same regulatory pathway as HFE. Although expression of mouse Hamp is normally greater during iron overload, Hfe-/- mice have inappropriately low expression of Hamp. We crossed Hfe-/- mice with transgenic mice overexpressing Hamp and found that Hamp inhibited the iron accumulation normally observed in the Hfe-/- mice. This argues against the crypt programming model and suggests that failure of Hamp induction contributes to the pathogenesis of hemochromatosis, providing a rationale for the use of HAMP in the treatment of this disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, transgenic expression of hepcidin prevented iron overload in Hfe−∕− (Nicolas et al., 2003) and Hbbth3∕+ (Gardenghi et al., 2010) mice, models of HH and β-thalassemia intermedia, respectively.”
From Pharmacological Targeting of the Hepcidin/Ferroportin Axis (2016) · cites this paper as Nicolas et al., 2003
Citations
Cites
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664 · cited 1×
“Most individuals affected with hereditary hemochromatosis are homozygous with respect to a missense mutation that disrupts the conformation of HFE, an atypical HLA class I molecule (ref”
BackgroundHepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697 · cited 1×
“It is synthesized predominantly in the liver, secreted as peptides of 20–25 amino acid”
BackgroundHepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417 · cited 1×
“Other individuals with anemia and inflammation have been reported with elevated urinary HAMP excretio”
BackgroundLEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324
Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233
Self-citationNicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214 · cited 1×
“Hamp -deficient mice are unresponsive to the hypoferremic effects of inflammation provoked by turpentine injectio”
BackgroundSelf-citationSevere iron deficiency anemia in transgenic mice expressing liver hepcidin
Nicolas, G., Bennoun, M., Porteu, A., Mativet, S., Beaumont, C., Grandchamp, B., Sirito, M., Sawadogo, M., Kahn, A., & Vaulont, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072632499 · Cited by 880
Self-citationMutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., & Camaschella, C. (2003) · Nature Genetics · doi:10.1038/ng1053 · Cited by 860 · cited 1×
“Recently, humans with severe hemochromatosis have been shown to have null mutations in the gene HAMP”
BackgroundWeinstein, D. A., Roy, C. N., Fleming, M. D., Loda, M. F., Wolfsdorf, J. I., & Andrews, N. C. (2002) · Blood · doi:10.1182/blood-2002-04-1260 · Cited by 632 · cited 1×
“Humans with constitutively active HAMP expression develop iron-refractory anemia associated with defective intestinal iron absorption and macrophage iron retention, similar to the anemia of chronic inflammatio”
BackgroundSelf-citation
Cited by
Items 301–310 of 310
Régulation de l'absorption du fer: données nouvelles
Cattan, D. (2004) · EMC - Hépatologie · doi:10.1016/s1155-1976(04)31500-7 · Cited by 5
Assesment of erythroferrone levels in neonates with anaemia of prematurity
El‐Hawy, M. A., Mohamed, M. S. S., Abdelsattar, S., & Ashour, N. M. (2023) · International Journal of Health Sciences · doi:10.53730/ijhs.v7ns1.14172
HEREDITARY HEMOCHROMATOSIS: THE ROLE OF PROTEINS IN IRON HOMEOSTASIS
do Carmo, J. F., Moreira, A. L. E., & Neto, B. R. D. S. (2023) · International Journal of Health Science · doi:10.22533/at.ed.1593392331058
Griffiths, W. J., & Cox, T. M. (2020) · doi:10.1093/med/9780198746690.003.0233_update_001
Intestine-Specific Ferroportin Ablation Rescues from Systemic Iron Overload in Mice
Castillo, C., GIM, S. C. M. M. F. F., & Das, N. K. (2026) · Nutrients · doi:10.3390/nu18020352 · Cited by 1
“However, its action is not intestine-specific and is most effective in disorders associated with ineffective erythropoiesis (e.g., thalassemia and sickle cell disease), where global Fpn1 inhibition provides a clear therapeutic benefit [37,38].”
de Carvalho, A. G. C. (2010) · theses.fr (ABES) · doi:10.70675/3eef4184z1db5z47f0z8097z1a1424d1940b
Surcharges en fer rares d’origine génétique : caractérisation clinique, fonctionnelle, et biologique
Bardou‐Jacquet, E. (2013) · theses.fr (ABES) · doi:10.70675/99eb557fz5edcz4fdezbd26z84ca08eab5aa
Le rôle de l'érythroferrone dans la régulation du métabolisme du fer
Sardo, U. (2020) · theses.fr (ABES) · doi:10.70675/d03e67aczc44bz4af9z8fa1zef080668f44f
Costa, A., Pilo, F., & Breccia, M. (2026) · Blood Reviews · doi:10.1016/j.blre.2026.101420 · Cited by 1
La homeostasis del hierro y una hormona: la hepcidina.
Barrios, Y., Acosta, E., Espinoza, M., Meléndez, A., & Méndez, D. (2007) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 2
Metadata
- Authors
- Nicolas, G., Viatte, L., Lou, D.-Q., Bennoun, M., Beaumont, C., Kahn, A., Andrews, N. C., & Vaulont, S.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Vaulont, Sophie
- Venue
- Nature Genetics
- Published
- 2003-04-21
- Volume
- 34
- Issue
- 1
- Pages
- 97-101
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2018391935
- Cited by
- 311
- References
- 25
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1 · 2023: 5 · 2022: 2 · 2021: 6 · 2020: 6 · 2019: 11 · 2018: 7 · 2017: 9 · 2016: 10 · 2015: 7 · 2014: 8 · 2013: 11 · 2012: 8
- FWCI
- 19.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- hereditary hemochromatosis, hepcidin, HFE gene, Hfe knockout mice, iron overload, hyperferremia, hepatic iron deposition, intestinal iron absorption, reticuloendothelial cells, iron homeostasis
- MeSH terms
- Hemochromatosis Protein, Animals, Crosses, Genetic, Hemochromatosis, Humans, Membrane Proteins, Mice, Transgenic, Phenotype, RNA, Messenger, Histocompatibility Antigens Class I, Gene Expression, Mice, Knockout, Iron Overload, Mutation, Missense, Antimicrobial Cationic Peptides, Mice, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.